Jasper Therapeutics, Inc. business relationships
Companies named in Jasper Therapeutics, Inc.’s 10-K filed 2026-03-30, and public companies whose annual reports name Jasper Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 5 / 100 Top 11% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in Jasper Therapeutics, Inc.’s annual report 2
“Under our license agreement with Amgen,” SEC filing
“addition, pursuant to our Exclusive License Agreement with Amgen Inc., Lonza Biologics, Inc. has been engaged to manufacture briquilimab” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.